Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension

ClinicalTrials.gov ID: NCT04880031

Public ClinicalTrials.gov record NCT04880031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 9:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomized, Blinded, Placebo-controlled Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With a Single Arm Open-label Extension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, blinded, placebo-controlled study of Efimosfermin in obese participants at risk for, or with biopsy-confirmed, nonalcoholic steatohepatitis (NASH), with a single arm open-label extension. It includes Parts A, B, C and D.

Study identification

NCT ID
NCT04880031
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
231 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2021 (Actual)
Primary completion
Oct 27, 2025 (Actual)
Completion
Oct 27, 2025 (Actual)
Last update posted
Jul 8, 2026

2021 – 2025

United States locations

U.S. sites
48
U.S. states
12
U.S. cities
37
Facility City State ZIP Site status
Central Research Associates Birmingham Alabama 35205 —
Arizona Liver Health Chandler Arizona 85224 —
Arizona Liver Health Peoria Arizona 85381 —
Arizona Liver Health Tucson Arizona 85712 —
Liver Institute PPLC Tucson Arizona 85712 —
QLMC Tucson Arizona 85712 —
Alliance Research Institute Canoga Park California 91304 —
Ark Clinical Research Fountain Valley California 92708 —
Fresno Clinical Research Center Fresno California 92720 —
Catalina Research Institute Montclair California 91763 —
Knowledge Research Center Orange California 92868 —
FOMAT Medical Research Oxnard California 93030 —
Inland Empire Clinical Trials Rialto California 92377 —
Southwest General Healthcare Center Fort Myers Florida 33907 —
Covenant Metabolic Specialists - Fort Myers Fort Myers Florida 33912 —
Evolution Clinical Trials Hialeah Gardens Florida 33016 —
Entrust Clinical Research Center Kendall Florida 33176 —
Galenus Group Lehigh Acres Florida 33976 —
G+C Research Group Miami Florida 33126 —
Miami Clinical Research Miami Florida 33155 —
Advanced Clinical Research Miami Florida 33156 —
Admed Research Miami Florida 33173 —
Century Research Miami Florida 33173 —
Panex Clinical Research Miami Lakes Florida 33014 —
Charter Research Orlando Florida 32803 —
Progressive Medical Research Port Orange Florida 32127 —
Covenant Metabolic Specialists - Sarasota Sarasota Florida 34240 —
Tandem Clinical Research Marrero Louisiana 70072 —
Kansas City Research Institute Kansas City Missouri 64131 —
Coastal Research Institute, LLC Fayetteville North Carolina 28304 —
Lillestol Research LLC Fargo North Dakota 58104 —
Velocity Clinical Research East Greenwich Rhode Island 02818 —
Accelemed Research Austin Texas 78745 —
Pinnacle Clinical Research - Austin Austin Texas 78757 —
Texas Liver Institute - Austin Austin Texas 78757 —
Apex Mobile Clinical Research Bellaire Texas 77401 —
South Texas Research Institute-Brownsville Brownsville Texas 78520 —
South Texas Research Institute-Edinburg Edinburg Texas 75839 —
Pinnacle Clinical Research - Georgetown Georgetown Texas 78626 —
Houston Research Institute Houston Texas 77079 —
LinQ Research, LLC Pearland Texas 77584 —
Quality Research, Inc San Antonio Texas 78209 —
American Research Corporation at Texas Liver Institute San Antonio Texas 78215 —
Pinnacle Clinical Research - San Antonio San Antonio Texas 78229 —
Velocity Clinical Research - Waco Waco Texas 76710 —
Olympus Family Medicine Salt Lake City Utah 84117 —
South Ogden Family Medicine South Ogden Utah 84405 —
Liver Institute NorthWest Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04880031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04880031 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →